Bay846, a new irreversible small molecule inhibitor of EGFR...

Investigational New Drugs 2012 / 12 Vol. 30; Iss. 6

Bay846, a new irreversible small molecule inhibitor of EGFR and Her2, is highly effective against malignant brain tumor models

Sharon L. Longo, David J. Padalino, Sandra McGillis, Kirstin Petersen, Hartmut Schirok, Oliver Politz, Gregory W. Canute, Dawn E. Post
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
DOI:
10.1007/s10637-011-9784-4
Date:
December, 2012
File:
PDF, 564 KB
english, 2012
Conversion to is in progress
Conversion to is failed